1,500
Participants
Start Date
May 26, 2021
Primary Completion Date
December 31, 2027
Study Completion Date
March 31, 2028
LiverCare
The LiverCare kits contains Streck tubes and PAX gene tubes, which will be collected at the surveillance schedule outlined above, but also prior to any liver biopsy or DSA measurement. For patients who have a histological diagnosis of allograft rejection who are undergoing treatment, serial monitoring of LiverCare will be performed following the schedule above. All research blood tests will be timed with standard clinical testing to avoid any additional needle sticks.
Icahn School of Medicine at Mount Sinai, New York
Westchester Medical Center, Valhalla
MedStar Georgetown University Hospital, Washington D.C.
University of Maryland Medical Center, Baltimore
Virginia Commonwealth University, Richmond
Duke University, Durham
Atrium Health, Charlotte
Medical Unversity of South Carolina, Charleston
Piedmont Healthcare, Atlanta
Tampa General Hospital, Tampa
University of Tennessee_Methodist Healthcare, Memphis
University of Cincinnati, Cincinnati
University of Michigan, Ann Arbor
Henry Ford Health System, Detroit
Washington Unversity in St. Louis, St Louis
University of Kansas Medical Center, Kansas City
University of Nebraska Medical Center/ Nebraska Medicine, Omaha
Tulane University, New Orleans
INTEGRIS Baptist Medical Center, Oklahoma City
Methodist Health System, Dallas
Baylor College of Medicine, Houston
Intermountain Medical Center, Murray
Keck Medical Center of USC, Los Angeles
University of Washington, Seattle
Massachusetts General Hospital, Boston
Beth Israel Deaconess Medical Center (BIDMC), Boston
Lead Sponsor
CareDx
INDUSTRY